APA

Payzin K. B., Savasoglu K., Alacacioglu I., Ozdemirkiran F., Mutlu B. B., Bener S., Calli A. O., Kucukzeybek B. B. & Aksun S. (20150723). JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms. : Clinical lymphoma, myeloma & leukemia.

Chicago

Payzin Kadriye Bahriye, Savasoglu Kaan, Alacacioglu Inci, Ozdemirkiran Fusun, Mutlu Belgin Berber, Bener Sadi, Calli Aylin Orgen, Kucukzeybek Betul Bolat and Aksun Saliha. 20150723. JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms. : Clinical lymphoma, myeloma & leukemia.

Harvard

Payzin K. B., Savasoglu K., Alacacioglu I., Ozdemirkiran F., Mutlu B. B., Bener S., Calli A. O., Kucukzeybek B. B. and Aksun S. (20150723). JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms. : Clinical lymphoma, myeloma & leukemia.

MLA

Payzin Kadriye Bahriye, Savasoglu Kaan, Alacacioglu Inci, Ozdemirkiran Fusun, Mutlu Belgin Berber, Bener Sadi, Calli Aylin Orgen, Kucukzeybek Betul Bolat and Aksun Saliha. JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms. : Clinical lymphoma, myeloma & leukemia. 20150723.